Morning Movers
Watch us on YouTube Live at 8:30AM EST

SPCE.NY -17.29%
Virgin Galactic – The company said recent material testing returned new data that requires further analysis, and it has “determined the most efficient and expedient path to commercial service is to complete this work now in parallel with the planned enhancement program.” The company therefore will delay its commercial flight service going forward.

GTLB.NQ 1.92%
Gitlab Inc – Made a stellar debut on the Nasdaq yesterday, the stock jumped about 35% above their offer price in their Nasdaq debut on Thursday, giving the software development platform a market capitalization of $14.9 billion, showing strong investor appetite for fast-growing software companies. The company’s stock opened at $94.25 and closed at $103.89, compared with the initial public offering price of $77 per share.

MRNA.NQ 3.05%
Moderna Inc – Back on watch trading higher premarket after yesterday’s rally that followed news the FDA had approved a third shot booster of the company’s vaccine for 65+ along with other high-risk groups.

GS.NY 1.23%
Goldman Sachs Group – Set to report earnings before the bell this morning.

UPST.NQ 1.64%
Upstart Holdings – Back on watch set to open in record higher territory for the second straight session, the cloud based, AI-lending platform is set to report earnings November 9th. The stock has doubled since its original technical breakout back in August.

PLUG.NQ 1.38%
Plug Power – Trading higher after yesterday’s pullback, multiple analyst upgrades and PT increases on the stock today. Plug announced multiple new deals earlier in the week as it continues its efforts to transform into a one-stop turnkey hydrogen solution with new partnerships with stationary power (GenSure) and transportation (JV and Renault), along with series of vertical acquisitions.

LMFA.NQ 49.13%
LM Funding America – No news, micro cap US based fintech with crypto ties rallying premarket. 4.4m share free float.

SNOA.NQ 28.79%
Sonoma Pharmaceuticals – Trading higher after receiving extended approval for its disinfectant against covid-19, Nanocyn in Australia.

Leave a Reply

Your email address will not be published.